Standard BioTools Files 8-K on Financials
Ticker: LAB · Form: 8-K · Filed: Feb 26, 2025 · CIK: 1162194
| Field | Detail |
|---|---|
| Company | Standard Biotools Inc. (LAB) |
| Form Type | 8-K |
| Filed Date | Feb 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K, disclosure
TL;DR
Standard BioTools dropped an 8-K on financials - check it out.
AI Summary
Standard BioTools Inc. filed an 8-K on February 26, 2025, reporting on its Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits. The filing pertains to the company's operations as of February 26, 2025, and includes information related to its financial performance and disclosures.
Why It Matters
This filing provides crucial updates on Standard BioTools Inc.'s financial condition and operational results, which are essential for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any unusual or immediate risks.
Key Numbers
- 001-34180 — SEC File Number (Identifies the company's filing with the SEC.)
- 77-0513190 — IRS Employer Identification Number (Company's tax identification number.)
Key Players & Entities
- Standard BioTools Inc. (company) — Registrant
- February 26, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- South San Francisco, California (location) — Principal Executive Offices
- Fluidigm Corp (company) — Former Company Name
FAQ
What specific financial results are being reported in this 8-K?
The filing indicates it covers 'Results of Operations and Financial Condition' but does not detail specific figures within the provided text.
What is the primary purpose of this 8-K filing?
The primary purpose is to report on the company's Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits.
When was Standard BioTools Inc. previously known by another name?
The company was formerly known as Fluidigm Corp, with a name change date of November 13, 2001.
Where are Standard BioTools Inc.'s principal executive offices located?
The principal executive offices are located at 2 Tower Place, Suite 2000, South San Francisco, California 94080.
What is the fiscal year end for Standard BioTools Inc.?
The fiscal year end for Standard BioTools Inc. is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 26, 2025 regarding STANDARD BIOTOOLS INC. (LAB).